Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Bacon

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
Journal of Viral Hepatitis|October 13, 2016
Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health studyE B Tapper, B R Bacon, M P Curry, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 29, 2006
Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3S F Drake, E H Morgan, C E Herbison, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trialA M Di Bisceglie, H L Bonkovsky, S Chopra, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
Hereditary hemochromatosis in liver transplantationM I Fiel, T D Schiano, H C Bodenheimer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1998
HFE gene knockout produces mouse model of hereditary hemochromatosisX Y Zhou, S Tomatsu, R E Fleming, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2013
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirinS C Gordon, E M Yoshida, E J Lawitz, et al.
Nature Genetics|August 1, 1996
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosisJ N Feder, A Gnirke, W Thomas, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Journal of Viral Hepatitis|October 13, 2016
Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health studyE B Tapper, B R Bacon, M P Curry, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 29, 2006
Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3S F Drake, E H Morgan, C E Herbison, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trialA M Di Bisceglie, H L Bonkovsky, S Chopra, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
Hereditary hemochromatosis in liver transplantationM I Fiel, T D Schiano, H C Bodenheimer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1998
HFE gene knockout produces mouse model of hereditary hemochromatosisX Y Zhou, S Tomatsu, R E Fleming, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2013
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirinS C Gordon, E M Yoshida, E J Lawitz, et al.
Nature Genetics|August 1, 1996
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosisJ N Feder, A Gnirke, W Thomas, et al.
Pageof 16